2022
DOI: 10.1186/s12885-022-09236-6
|View full text |Cite
|
Sign up to set email alerts
|

Genome-wide association study of serum tumor markers in Southern Chinese Han population

Abstract: Background Serum indicators AFP, CA50, CA125, CA153, CA19-9, CEA, f-PSA, SCC-Ag have been confirmed as tumor markers (TMs). We conducted a genome-wide association study on 8 tumor markers of our 427 Han population in southern China, in order to identify genetic loci that are significantly associated with the level of 8 tumor markers. Methods We use Gene Titan multi-channel instrument and Axiom Analysis Suite 6.0 software for genotyping. We used IMP… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 41 publications
0
2
0
Order By: Relevance
“…Tumor antigens and ectopic hormones, such as CEA, AFP, NSE, CA50, CA724, CA125, etc., are currently the most often utilized tumor biomarkers in clinic [27][28][29][30][31]. CEA is a broad-spectrum tumor marker that can be used to assess e cacy, monitor disease progression, and predict prognosis in lung cancer, colorectal cancer, breast cancer, and other cancers [32][33][34].…”
Section: Discussionmentioning
confidence: 99%
“…Tumor antigens and ectopic hormones, such as CEA, AFP, NSE, CA50, CA724, CA125, etc., are currently the most often utilized tumor biomarkers in clinic [27][28][29][30][31]. CEA is a broad-spectrum tumor marker that can be used to assess e cacy, monitor disease progression, and predict prognosis in lung cancer, colorectal cancer, breast cancer, and other cancers [32][33][34].…”
Section: Discussionmentioning
confidence: 99%
“…Tumor antigens and ectopic hormones, such as CEA, AFP, NSE, CA50, CA724, CA125, etc., are currently the most often utilized tumor biomarkers in clinic [ 32 36 ]. CEA overexpress in several type of tumor which associate with cell proliferation and tumor progression is a broad-spectrum tumor marker that can be used to assess efficacy, monitor disease progression, and predict prognosis in lung cancer, colorectal cancer, breast cancer, and other cancers [ 37 – 40 ].…”
Section: Discussionmentioning
confidence: 99%